SMI's 21st Pain Therapeutics Virtual Conference
May 10 – May 11, 2021
Sponsored by: MD Biosciences and Transpharmation Chaired by Michael Scherz, Founder & CEO, Metys Pharma and Naheed Mirza, Early Development Pain & CNS Specialist Explore Cutting Edge Drug Discovery Science and Key Clinical-Stage Pain Therapies in the Pipeline SMi’s 21st Pain Therapeutics Conference will focus on looking into research within pain therapeutics. In particular, the long-term (HEAL) initiative will be discussed and its role in advancing research to reduce the risks of opioid use and misuse and improve pain management, thereby reducing reliance on opioids and the national opioid public health crisis. Talks will also address the importance of sex, gender and race in pain research, including biomarkers, molecular targets, clinical and experimental models of pain.